
GEOVAX LABS INC- WARRANTS
Acción · US3736781192 · GOVXW (XNAS)
0,03 USD
04.06.2025 16:27
Cotizaciones actuales de GEOVAX LABS INC- WARRANTS
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria |
---|---|---|---|---|---|
![]() NASDAQ |
GOVXW
|
USD
|
04.06.2025 16:27
|
0,03 USD
| 0,03 USD
-3,70 %
|
Rendimiento
Día | Semana | Mes | 3 meses | 6 meses | 1 año | 5 años |
---|---|---|---|---|---|---|
0,00 % | -0,27 % | 83,66 % | -66,39 % | -73,80 % | -10,37 % | -96,05 % |
Perfil de la empresa para GEOVAX LABS INC- WARRANTS Acción
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is also developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; GEO-EM01 for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. GeoVax Labs, Inc. has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.
Datos de la empresa
Nombre GEOVAX LABS INC- WARRANTS
Empresa GeoVax Labs, Inc.
Símbolo GOVXW
Sitio web
https://www.geovax.com
Mercado principal
NASDAQ

ISIN US3736781192
Tipo de valor Acción
Sector Healthcare
Industria Biotechnology
CEO Mr. David Alan Dodd
Capitalización de mercado 12 Mio
País Estados Unidos de América
Moneda USD
Empleados 0,0 T
Dirección 1900 Lake Park Drive, 30080 Smyrna
Símbolos de cotización
Nombre | Símbolo |
---|---|
NASDAQ | GOVXW |
Otras acciones
Los inversores que tienen GEOVAX LABS INC- WARRANTS también tienen las siguientes acciones en su cartera:
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras.
Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.